首页> 外文OA文献 >PDB33 COST-EFFECTIVENESS OF THE PDM-PROVALUE STUDY PROGRAM IN INSULIN-TREATED PATIENTS WITH TYPE 2 DIABETES MELLITUS FROM THE GERMAN STATUTORY HEALTHCARE PERSPECTIVE

【2h】

PDB33 COST-EFFECTIVENESS OF THE PDM-PROVALUE STUDY PROGRAM IN INSULIN-TREATED PATIENTS WITH TYPE 2 DIABETES MELLITUS FROM THE GERMAN STATUTORY HEALTHCARE PERSPECTIVE

机译：PDM-Provalue研究计划的PDB33胰岛素治疗患者的成本效益2型糖尿病患者来自德国法定医疗保健的角度

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
F. Sailer; M. Pobiruchin; A. Müller; J. Weissmann; L. Heinemann; B. Kulzer; W. Schramm;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Integrated personalized diabetes management improves glycemic control in patients with insulin-treated type 2 diabetes: Results of the PDM-ProValue study program [J] . Kulzer Bernhard, Daenschel Wilfried, Daenschel Ingrid, Diabetes research and clinical practice . 2018,第期

机译：综合个性化糖尿病管理改善了胰岛素治疗的2型糖尿病患者的血糖控制：PDM-Provalue研究计划的结果
2. COST-EFFECTIVENESS OF INSULIN DEGLUDEC/INSULIN ASPART (IDEGASP) COMPARED WITH BIPHASIC INSULIN ASPART (BIASP 30) IN PATIENTS WITH TYPE 2 DIABETES MELLITUS FROM A MEXICAN HEALTHCARE PERSPECTIVE [J] . Sanchez-Pedraza V, Hansen B. B., Gundgaard J., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第7期

机译：与双生胰岛素ASPART（BIASP 30）相比，葡聚糖/胰岛素ASPART（IDEGASP）在患有墨西哥卫生保健的2型糖尿病患者中的成本效益
3. Disease management programs for patients with type 2 diabetes mellitus in Germany: a longitudinal population-based descriptive study [J] . Michael Mehring, Ewan Donnachie, Florian Cornelius Bonke, Diabetology and Metabolic Syndrome . 2017,第1期

机译：德国2型糖尿病患者的疾病管理计划：一项基于人群的纵向描述性研究
4. Patient Perceptions of the Use of a Technology-Augmented Healthcare System for the Self-care of Type 2 Diabetes Mellitus and/or Hypertension [C] . Mian Yan International Conference on Applied Human Factors and Ergonomics . 2019

机译：患者对使用技术增强的医疗保健系统进行2型糖尿病和/或高血压的使用的看法
5. Effect of dosing regimens on medication use, healthcare resource utilization, and costs in Medicaid enrolled type 2 diabetes mellitus patients [D] . Jayawant, Sujata S. 2008

机译：剂量方案对纳入Medicaid的2型糖尿病患者的用药，医疗资源利用和费用的影响
6. Disease management programs for patients with type 2 diabetes mellitus in Germany: a longitudinal population-based descriptive study [O] . Michael Mehring, Ewan Donnachie, Florian Cornelius Bonke, 2017

机译：德国2型糖尿病患者的疾病管理计划：一项基于人群的纵向描述性研究
7. PDB14 COST-EFFECTIVENESS OF MONO- AND COMBINATION THERAPY WITH PIOGLITAZONE COMPARED TO GLICLAZIDE IN PATIENTS WITH TYPE-2-DIABETES MELLITUS FROM A GERMAN STATUTORY HEALTH CARE PERSPECTIVE [O] . Schramm W, Neeser K, Mast O, 2004

机译：从德国法定卫生保健角度考虑，单药和联合疗法与吡格列酮相比于格列齐特的PDB14成本效益与2型糖尿病患者

PDB33 COST-EFFECTIVENESS OF THE PDM-PROVALUE STUDY PROGRAM IN INSULIN-TREATED PATIENTS WITH TYPE 2 DIABETES MELLITUS FROM THE GERMAN STATUTORY HEALTHCARE PERSPECTIVE

著录项

引文网络

相似文献

相关主题

期刊订阅